Cefpodoxime is an oral third-generation cephalosporin prodrug (as its proxetil ester) used for respiratory and urinary tract infections, offering enhanced Gram-negative stability. Simson Pharma's Cefpodoxime reference standard and impurities support compendial testing for this widely prescribed oral cephalosporin.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Cefpodoxime Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.